Failure to compensate pelvic mesh implant victims ‘morally unacceptable’, say campaigners | Vaginal mesh implants
Years after thousands of women experienced life-altering complications following the implantation of transvaginal mesh, a government response to provide financial redress remains stalled, sparking outrage from patient advocates. The lack of action is described as “morally unacceptable” as affected women face ongoing physical and mental health challenges and in some cases, financial ruin.
The Scope of the Harm
Pelvic mesh was once widely considered a gold standard treatment for stress incontinence and prolapse, conditions often occurring after childbirth or menopause. However, many women who received these implants experienced debilitating complications. These include difficulties walking, working, and, in some cases, require complex surgery for removal – a procedure likened to removing chewing gum from hair – which itself carries risks of organ injury, bleeding, infection, and blood clots.
A Two-Year Delay
The current impasse stems from a lack of commitment from ministers to implement the recommendations outlined in the 2024 Hughes report. This report, commissioned in response to the First Do No Harm review led by Julia Cumberlege, detailed nine recommendations for addressing harms caused by pelvic mesh, sodium valproate, and the hormone pregnancy test Primodos. Dr. Henrietta Hughes, England’s patient safety commissioner, initially set out plans for financial redress two years ago, but no timetable for compensation has been established.
The Human Cost
The delay is taking a significant toll on those affected. Kath Sansom, founder of the advocacy group Sling the Mesh, described the escalating frustration and despair among members, with some facing job loss, home sales, and marital breakdowns. She shared accounts of women expressing suicidal thoughts, highlighting the profound impact of unresolved pain and lack of accountability.
Political Pressure and Future Steps
Labour MP Sharon Hodgson, whose mother suffered complications from a pelvic mesh implant, labeled the government’s inaction “insulting.” She emphasized that the lack of response is not simply about a report, but about acknowledging the real harm experienced by women and families who were, as she stated, “gaslit” and told their suffering was imagined. Dr. Hughes has now stated she will directly approach the prime minister to advocate for action.
While the Department of Health and Social Care acknowledges the significant impact of sodium valproate and pelvic mesh, it maintains that a response is “complex” and requires a “fair, balanced and sensitive” approach. The department indicated This proves “carefully considering” the Hughes report and aims to provide an update at an unspecified time.
Frequently Asked Questions
What is the Hughes report?
The Hughes report, published in 2024, outlined plans for financial redress for women harmed by pelvic mesh implants and children disabled as a result of their mothers using the epilepsy drug sodium valproate during pregnancy.
What was the First Do No Harm review?
The First Do No Harm review, led by Julia Cumberlege, identified issues related to pelvic mesh, sodium valproate, and Primodos and made nine recommendations for delivering justice to those harmed.
What is the government’s current position on compensation?
The government has acknowledged the impact of pelvic mesh and sodium valproate but has not committed to a timetable for providing compensation, stating the issue is complex and requires careful consideration.
What role should government play in addressing harms caused by medical interventions, and how can systems be improved to prevent similar situations in the future?